INSIGHTS ON DRUG DEVELOPMENT

• AI-Enabled Phenotypic Analysis Of Label-Free Intestinal Organoids

  Discover how advanced 3D models and AI-enabled imaging techniques revolutionize organoid research, which provides accurate phenotypic analysis to monitor growth and development in various organoid types.

• Doubling Up For Speed In Biomanufacturing

  Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.

• How To Confidently Predict Toxicity Of Preclinical Drug Candidates

  Incorporating Liver-Chips into preclinical workflows could reduce drug-induced liver injury-related trial failures. Review this quantitative framework for integrating Liver-Chip data into pharmaceutical decision-making.

• Addressing Raw Material Handling Challenges By Dry Granulation

  Handling multi-ton quantities of buffers, salts, and stabilizing chemicals in manufacturing can be difficult. Discover how dry granulation improves efficiency, safety, and process reliability.

• Amorphous Stability: Mesoporous Silica For Poor Glass Formers

  6/5/2025

  Discover how mesoporous silica outperforms polymeric solid dispersions in stabilizing poor glass formers, as well as how it offers a novel approach to enhance amorphous drug stability and bioavailability.

• Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics

  11/6/2024

  Unlock the potential of antibody-drug conjugates (ADCs) by exploring our novel payloads, designed for easy access and evaluation, to accelerate your ADC drug development with proven efficacy and safety.

• Your AKTA Oligosynt™ System : It's More Than A Machine

  2/9/2026

  Discover how early choices in oligo synthesis workflows shape performance. Learn what to consider across design, reagents, and system optimization to build a process ready for smooth scale‑up.

• Comprehensive GMP Testing Services

  3/31/2025

  Eurofins delivers global GMP testing with 45+ facilities, ensuring regulatory acceptance, quality, and trusted service from starting materials to finished products.

• Cost Modeling Analysis Of AAV And LV Manufacturing

  3/31/2026

  Manufacturing scale plays a critical role in viral vector economics. Compare AAV and LV production scenarios to gain insight into how intermediate-scale strategies can reduce cost and risk.